World's Best Scientists 2026 revealed!
Nathalie Costedoat-Chalumeau

Nathalie Costedoat-Chalumeau

D-Index & Metrics

Medicine

D-Index
86
Citations
29528
World Ranking
14054
National Ranking
454

Overview

Nathalie Costedoat-Chalumeau is affiliated with Université Paris Cité in France. Their primary field of study is Medicine, with a significant focus on Rheumatology, reflected in 178 publications. Additional subfields of interest include Public Health, Environmental and Occupational Health; Immunology; Pulmonary and Respiratory Medicine; and Genetics.

The scientist's research topics encompass Systemic Lupus Erythematosus Research, Pregnancy and Medication Impact, Renal Diseases and Glomerulopathies, Reproductive System and Pregnancy, Renal Cell Carcinoma Treatment, Platelet Disorders and Treatments, and Peripheral Neuropathies and Disorders.

Notable recent papers authored or co-authored by Nathalie Costedoat-Chalumeau include:

  • 2023 ACR/EULAR antiphospholipid syndrome classification criteria, 2023, Annals of the Rheumatic Diseases
  • The 2023 ACR/EULAR Antiphospholipid Syndrome Classification Criteria, 2023, Arthritis & Rheumatology
  • 2021 DORIS definition of remission in SLE: final recommendations from an international task force, 2021, Lupus Science & Medicine
  • Severity of COVID-19 and survival in patients with rheumatic and inflammatory diseases: data from the French RMD COVID-19 cohort of 694 patients, 2020, Annals of the Rheumatic Diseases
  • Hydroxychloroquine to Prevent Recurrent Congenital Heart Block in Fetuses of Anti-SSA/Ro-Positive Mothers, 2020, Journal of the American College of Cardiology

The scientist frequently publishes in several medical journals, including:

  • La Revue de Médecine Interne
  • Annals of the Rheumatic Diseases
  • Revue du Rhumatisme
  • Lara D. Veeken
  • The Lancet Rheumatology

Frequent collaborators in Nathalie Costedoat-Chalumeau's research include:

  • Véronique Le Guern
  • É. Hachulla
  • Anna Moltó
  • Nathalie Morel
  • Zahir Amoura

Best Publications

  • 2019 European League Against Rheumatism/American College of Rheumatology Classification Criteria for Systemic Lupus Erythematosus

    Martin Aringer;Karen Costenbader;David Daikh;Ralph Brinks

  • EULAR recommendations for the management of antiphospholipid syndrome in adults

    Maria G Tektonidou;Laura Andreoli;Marteen Limper;Zahir Amoura

  • The EULAR Points to Consider for Use of Antirheumatic Drugs Before Pregnancy, and During Pregnancy and Lactation

    Carina Götestam Skorpen;Maria Hoeltzenbein;Angela Tincani;Rebecca Fischer-Betz

  • EULAR recommendations for women's health and the management of family planning, assisted reproduction, pregnancy and menopause in patients with systemic lupus erythematosus and/or antiphospholipid syndrome

    L. Andreoli;G. K. Bertsias;N. Agmon-Levin;S. Brown

  • Treat-to-target in systemic lupus erythematosus: recommendations from an international task force

    Ronald van Vollenhoven;Marta Mosca;George Bertsias;David Isenberg

  • Maternal Use of Hydroxychloroquine Is Associated With a Reduced Risk of Recurrent Anti-SSA/Ro-Antibody–Associated Cardiac Manifestations of Neonatal Lupus

    Peter M. Izmirly;Nathalie Costedoat-Chalumeau;Cecilia N. Pisoni;Munther A. Khamashta

  • Clinical efficacy of hydroxychloroquine in patients with covid-19 pneumonia who require oxygen: observational comparative study using routine care data.

    Matthieu Mahévas;Viet Thi Tran;Mathilde Roumier;Amélie Chabrol

  • CNS involvement and treatment with interferon-α are independent prognostic factors in Erdheim-Chester disease : a multicenter survival analysis of 53 patients.

    Laurent Arnaud;Baptiste Hervier;Antoine Néel;Mohamed A. Hamidou

  • Safety of hydroxychloroquine in pregnant patients with connective tissue diseases: a study of one hundred thirty-three cases compared with a control group.

    Nathalie Costedoat-Chalumeau;Zahir Amoura;Pierre Duhaut;Du Le Thi Huong

  • A framework for remission in SLE: consensus findings from a large international task force on definitions of remission in SLE (DORIS)

    Ronald van Vollenhoven;Alexandre Voskuyl;George Bertsias;Cynthia Aranow

  • Low blood concentration of hydroxychloroquine is a marker for and predictor of disease exacerbations in patients with systemic lupus erythematosus.

    Nathalie Costedoat-Chalumeau;Zahir Amoura;Jean-Sébastien Hulot;Hala Abou Hammoud

  • Cardiovascular involvement, an overlooked feature of Erdheim-Chester disease: report of 6 new cases and a literature review.

    Julien Haroche;Zahir Amoura;Elisabeth Dion;Bertrand Wechsler

  • Genome-wide association meta-analysis in Chinese and European individuals identifies ten new loci associated with systemic lupus erythematosus

    David L. Morris;Yujun Sheng;Yujun Sheng;Yan Zhang;Yong Fei Wang

  • Anti-HMGCR autoantibodies in European patients with autoimmune necrotizing myopathies: inconstant exposure to statin.

    Yves Allenbach;Laurent Drouot;Aude Rigolet;Jean Luc Charuel

  • Effect of anakinra versus usual care in adults in hospital with COVID-19 and mild-to-moderate pneumonia (CORIMUNO-ANA-1): a randomised controlled trial

    Pierre-Louis Tharaux;Gilles Pialoux;Arthur Pavot;Xavier Mariette

  • State of the art: Reproduction and pregnancy in rheumatic diseases.

    Monika Østensen;Laura Andreoli;Antonio Brucato;Irene Cetin

  • Rituximab use in the catastrophic antiphospholipid syndrome: descriptive analysis of the CAPS registry patients receiving rituximab.

    Horacio Berman;Ignasi Rodríguez-Pintó;Ricard Cervera;Nathalie Morel

  • Restoration of regulatory and effector T cell balance and B cell homeostasis in systemic lupus erythematosus patients through vitamin D supplementation

    Benjamin Terrier;Benjamin Terrier;Benjamin Terrier;Nicolas Derian;Nicolas Derian;Yoland Schoindre;Wahiba Chaara;Wahiba Chaara

  • Very low blood hydroxychloroquine concentration as an objective marker of poor adherence to treatment of systemic lupus erythematosus.

    Nathalie Costedoat-Chalumeau;Zahir Amoura;Jean-Sébastien Hulot;Guy Aymard

  • COVID-19 outcomes in patients with inflammatory rheumatic and musculoskeletal diseases treated with rituximab: a cohort study.

    Jérôme Avouac;Elodie Drumez;Eric Hachulla;Raphaèle Seror

Frequent Co-Authors

Jean-Charles Piette
Jean-Charles Piette Sorbonne University
Patrice Cacoub
Patrice Cacoub Sorbonne University
Zahir Amoura
Zahir Amoura Université Paris Cité
David Saadoun
David Saadoun Université Paris Cité
Olivier Fain
Olivier Fain Université Paris Cité
Eric Hachulla
Eric Hachulla University of Lille
Luc Mouthon
Luc Mouthon Université Paris Cité
Bertrand Wechsler
Bertrand Wechsler Sorbonne University
Lucile Musset
Lucile Musset Sorbonne University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Medicine is a broad and dynamic field, offering a wide range of entry points and career pathways. For those seeking flexibility and affordability, online education has opened new doors in healthcare professions. From certification and licensure programs to advanced degrees, students can now access quality training without relocating or pausing full-time work.

For individuals interested in healthcare administration, pursuing the cheapest medical coding certification online can be an excellent first step. This credential helps students build a foundation in medical records management and insurance processing.

Nursing remains one of the most in-demand fields. Students can find some of the most affordable online nurse practitioner programs or enroll in accessible online nursing courses to launch or advance their nursing careers.

For experienced nurses, opportunities for leadership, research, and teaching are expanding. Earning your phd nursing education online can prepare you for academic and executive roles in healthcare systems.

Exploring these related online degrees can help you tailor your education and skills to meet the evolving needs of the healthcare sector.

Best Scientists Citing Nathalie Costedoat-Chalumeau

Trending Scientists

Recently Published Articles